A12359 | Pages: NA | Jul 2022 | 468 Views | ||
Author(s) : Onkar Sumant | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Small Molecule Api Market
Request Now !Small active pharmaceutical ingredients (API) molecule is an organic component with low molecular weight. It is an active ingredient used in pharmaceuticals and biological procedures. In addition, API can be used as a combination in finished pharmaceutical products. Being a vital element, its requirement is high in the pharmaceutical industry. The molecule is effective in the diagnosis, treatment, and prevention of various diseases. Small molecules may be used as research tools to probe biological function as well as lead in the development of new therapeutic agents. Some can obstruct a specific function of a protein or interrupt protein-protein interactions.
The molecular value of the small API is approximately 900 Daltons and size on the order of 1 nm. Due to its low molecular weight, the body absorbs this active solution quickly.
Market Scope and Structure Analysis
Report Metric | Details |
Market Size Available for Years | 2020–2030 |
Base Year Considered | 2020 |
Forecast Period | 2021–2030 |
Forecast Unit | Value (USD) |
Segments Covered | Product Type, Application, End User, and Region |
Regions Covered | North America, Europe, Asia-Pacific, LAMEA |
Companies Covered | Lonza, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Aesica Pharmaceuticals Ltd., Albemarle Corporation, Cambrex Corporation, BASF SE, Gland Pharma Limited, Gilead Sciences, Inc., AstraZeneca Plc., Baxter International Inc., Boehringer Ingelheim International GmbH, Celgene Corporation, Piramal Pharma Solutions, Recipharm AB, Evonik Industries AG, Glenmark Pharmaceuticals Limited, Siegfried AG, AbbVie Contract Manufacturing, Aurinia Pharmaceuticals Inc., Bayer AG, Patheon, and CordenPharma International. |
COVID-19 Impact analysis
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the small molecule API market.
Top Impacting Factors
Market Trends
New product launches to flourish the market
In March 2019, GHO Capital, a European healthcare investor, acquired a majority stake in Sterling Pharma Solutions, a manufacturer of small molecule APIs.
In January 2019, Cambrex Corporation, a manufacturer of small molecule innovator and generic APIs, acquired Avista Pharma Solutions, a contract manufacturing organization from Ampersand Capital Partners. The acquisition is expected to provide Cambrex the access to its manufacturing facilities.
In November 2019, Novartis announced the acquisition of CellforCure—a France-based CDMO—for producing molecules in-house, which was earlier contracted to CellforCure. These initiatives undertaken by key players are anticipated to boost the market growth.
In January 2020, Merck announced its strategic collaboration for the oncology platform with Taiho Pharmaceutical Co, Ltd. and Taiho Pharmaceutical Co., Ltd. to expand its focus on small molecule inhibitors for cancer research.
Key Segments Covered
Segment | Subsegment |
Product |
|
Type |
|
Application |
|
End User |
|
Region |
|
Key Benefits of the Report
Questions answered in the Small Molecule API Report
Key Market Segments
Segments | Sub-segments |
---|---|
By Product |
|
By Type |
|
By Application |
|
By End User |
|
By Region |
|
Key Market Players
Loading Table Of Content...
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers